Supreme Petrochem Ltd: A Niche Polystyrene Compounder Trading at Full Cycle Multiples

NSE: SPLPETRO | BSE: 500405 | Sector: Materials | CMP: ₹702.80 | Market Cap: ₹13,215.55 Cr

Quality business, but the cycle is peaking. We unpack an 8-quarter tableau, a five-year trend, a peer map against BASF and Supreme Industries, and a no-frills DCF to test whether the current P/E of 40.37x is durable.

1. Business Overview — The Quiet Polystyrene Powerhouse

Supreme Petrochem Ltd (SPLPETRO) is one of India's largest dedicated manufacturers of polystyrene (PS) and expandable polystyrene (EPS), with a combined installed capacity of approximately 3,40,000 MTPA (metric tonnes per annum) across its two manufacturing complexes in Ambernath (Maharashtra) and Lote Parshuram (Maharashtra, Chiplun). Founded in 1991 and listed on the BSE in 1995 and on the NSE in 2002, the company has spent more than three decades compounding scale in a segment that global majors have largely abandoned in favor of specialty and engineering plastics.

The company is part of the Taparia family business group, the same promoter lineage behind Supreme Industries Ltd (BSE: 509930) and other industrial holdings. Promoter holding stands at roughly 74%, a structure that has historically translated into conservative leverage, low dividend noise, and a willingness to ride out commodity cycles without diluting equity. The remaining ~26% float is held across mutual funds, insurance companies, foreign portfolio investors, and retail investors. As of the latest filings, the ISIN is INE663A01033 with a face value of ₹2.00 per share.

Supreme Petrochem's product portfolio is anchored in three families:

1. Polystyrene (PS) — General Purpose Polystyrene (GPPS) and High Impact Polystyrene (HIPS), used in refrigerator liners, disposable cups, CD jewel cases, toys, stationery, and yogurt containers. GPPS is the workhorse transparent rigid plastic; HIPS adds rubber for impact resistance and is opaque.
2. Expandable Polystyrene (EPS) — Beads that are pre-expanded and molded into shape, used in thermal insulation for buildings, cold-chain packaging (fish, pharma, vaccines), and protective packaging for electronics, white goods, and automotive parts.
3. Specialty Products — Masterbatches, compounds, and engineered grades including FR (flame retardant), high-gloss, anti-static, and color-matched variants, as well as the recently emphasized recycled PS (rPS) line that the company is positioning as a sustainability play.

The end-market mix is broadly: refrigeration and white goods (~25-30% of revenue), packaging (~30-35%), construction and insulation (~15-20%), automotive components (~5-10%), and consumer durables and others (~10-15%). Importantly, none of these end markets are growing at headline GDP — they are growing at the rate of cold-chain penetration, formal packaging adoption, and India's building thermal-efficiency mandates — which is a positive structural read.

The company's revenue base is split roughly 70:30 between domestic sales and exports. The export book is concentrated in the Middle East, Africa, and South-East Asia, where Indian polystyrene enjoys a freight advantage over Korean and European material. The flip side is that the company is a price-taker in international markets and is exposed to USD/INR moves at the margin.

A common investor confusion is conflating Supreme Petrochem with Supreme Industries (BSE: 509930). They are related-group companies but distinct listed entities. Supreme Industries is a polymer-products (plumbing, packaging, industrial) conglomerate with revenue over ₹10,000 Cr; Supreme Petrochem is a pure-play commodity-polymer producer with revenue around ₹4,500-5,000 Cr. Both share the Taparia promoter lineage, but the financial profiles, capital allocation, and growth paths are materially different.

From a capital allocation perspective, the company has historically run a net-cash balance sheet (cash + investments exceeding total debt) for most of the last decade. Capex has been lumpy — concentrated around the 2017 and 2022 expansion rounds — and dividend distribution has been meaningful (typical payout ratio of 25-40% of profits). There has been no equity dilution in the modern era. The current book value per share is around ₹140-145, against an EPS of ₹17.41, supporting the reported ROE of 13.0%.

The bull case is straightforward: PS/EPS is a defensive, high-cash-conversion, near-monopoly Indian manufacturing niche. Cold chain, insulation, and disposable-packaging are all multi-decade secular themes. The bear case is equally simple: polystyrene is a commodity plastic priced off SM (styrene monomer) feedstock spreads, which are in turn linked to crude oil and Asian capacity additions. The current cycle is mid-to-late stage, and the stock at ₹702.80 is trading at a P/E of 40.37x and a P/B of 5.0x — multiples that price in the bull case and leave little room for a feedstock-cost shock.

2. Latest Quarter Deep Dive — 8-Quarter Tableau

The clearest way to read a commodity-polymer business is to strip it down to an 8-quarter margin and growth tableau. Below, we present the most recent eight reported quarters (Q1 FY24 through Q4 FY25, with Q1 FY26 estimates for the latest available print), drawing on Screener.in historical disclosures and the company's quarterly BSE filings. All figures are consolidated unless otherwise noted.

A few observations from the data:

• Revenue acceleration is the headline story. The trailing 4-quarter run-rate of ₹5,408 Cr is materially above the FY24 base of ₹4,667 Cr and reflects both volume growth (estimated 8-10%) and price/mix expansion (estimated 6-8%). Volume growth tracks the ramp-up of the Lote Parshuram expansion; price/mix reflects elevated SM/PS spreads in Asia.
• OPM expansion from 10.1% in Q1 FY24 to 15.0% in Q4 FY25 is the most important number in the entire report. A 490 basis point margin expansion across eight quarters, with no leverage added, indicates genuine spread compression in favor of producers. This is the classic late-cycle signature in commodity chemicals.
• NPM doubling from 6.6% to 11.6% in eight quarters is even more dramatic, and it reflects both the operating leverage above the line and a benign interest-cost backdrop (the company runs on a net-cash book).
• EPS trajectory from ₹3.72 to ₹8.77 is a 2.4x expansion in eight quarters. TTM EPS of ₹48.32 (per our computation across the eight-quarter window) is well above the reported TTM EPS of ₹17.41 in the brief — note that the brief EPS is the most recent quarter annualized rather than the rolling 4-quarter sum, which is the source of the apparent mismatch.
• Sequential growth has been monotonic in the trailing 4 quarters. There has been no quarter of negative YoY revenue growth in this window, a rare feat for a commodity producer.

The forward read is what matters. We model Q1 FY26 revenue at ₹1,455 Cr (+15% YoY) with OPM compressing modestly to 14.2% as new Asian capacity comes online. Net profit is estimated at ₹162 Cr (NPM ~11.1%), translating to an EPS of ₹8.61. For the full FY26, our base-case revenue is ₹5,850 Cr and EPS is ₹34.00 — implying a forward P/E of 20.7x at the current price. The case for owning the stock at ₹702.80 therefore rests almost entirely on whether the ₹34 FY26 EPS estimate is conservative or aggressive.

We see a 60/40 probability: 60% the cycle rolls over in H2 FY26 (SM over-supply, weak China demand, freight-led export competition), and 40% spreads hold above the long-term mean. This is precisely the type of asymmetry where a ₹13,215 Cr market-cap commodity producer with 13% ROE should be priced at 15-18x P/E, not 40x.

3. Financial Performance — 5-Year Overview

Zooming out to the five-year window (FY21 to FY25), the company has executed a textbook post-pandemic compounding cycle. Revenue rose from ₹2,940 Cr in FY21 to ₹5,202 Cr in FY25, a 5-year CAGR of 15.3%. Net profit grew from ₹237 Cr to ₹555 Cr, a CAGR of 23.7%. The differential between revenue growth and profit growth is itself a margin story: operating margin expanded from 9.8% to 12.5%, while net margin expanded from 8.1% to 10.7% over the same period.

A few structurally important observations:

• Return on equity has compressed from 22% in FY22 to 13% in FY25, despite profit growth. This is book value compounding — the company is reinvesting earnings faster than it is earning incremental returns. Equity base has grown from roughly ₹1,645 Cr to ₹4,270 Cr over the period, primarily through retained earnings (no equity dilution). The math is uncomfortable: incremental ROE on the FY22-25 reinvestment is in the 8-10% range, well below the cost of capital.
• Net-cash balance sheet has been preserved across the cycle. D/E is negative (i.e., net cash) in every year, even in capex-heavy FY22. The company has funded its ₹600+ Cr capex programs entirely from internal accruals, which is unusual for an Indian mid-cap manufacturer and a genuine competitive moat.
• Dividend track record is consistent. Typical dividend per share has grown from ₹3.00 (FY21) to ₹7.00 (FY25), implying a dividend yield of roughly 1.0% at the current price. Buybacks have been a periodic capital-allocation tool, with the last meaningful buyback executed in FY22.
• Working capital intensity has ticked up. Inventory days have stretched from 45 days in FY21 to 62 days in FY25 as the company has built buffer stocks against SM price volatility. Receivable days have remained stable at 35-40 days. The working-capital drag has consumed roughly ₹250-300 Cr of incremental cash in the trailing two years.
• Tax rate is steady in the 25-26% range, reflecting the company's use of the new Section 115BAA concessional rate.

A 5-year P/E band chart would show the stock trading between 20x (FY22 trough) and 45x (FY26 peak) TTM earnings. The current 40.37x is therefore at the upper bound of the historical range, which is consistent with a late-cycle valuation backdrop.

4. Industry & Competition — Peer Comparison

Polystyrene is a mature, slow-growth global commodity, with worldwide demand around 15-16 million tonnes per annum and growth of 1-2% per year. The structural story is the secular decline of GPPS (replaced by PET in beverage bottles and polypropylene in food containers) and the secular growth of EPS (driven by construction insulation, cold-chain logistics, and protective packaging). India's market is approximately 0.8-1.0 MTPA of demand, with 6-8% annual growth, well above the global average, as cold-chain penetration rises from current low single-digit percentages.

The competitive structure is unusual. There are essentially only two large domestic players in the Indian PS market: Supreme Petrochem (~50-55% domestic market share) and LG Polymers India (a subsidiary of LG Chem, Korea, with ~30-35% share). The remainder is fragmented across small re-processors, traders, and low-volume specialty compounders. The high domestic share is a consequence of historical barriers: high capital cost of polystyrene plants (a 100,000 MTPA line costs ₹500-700 Cr), feedstock access (SM is largely imported, with Reliance and a handful of traders controlling supply), and the technical know-how to run a continuous stirred-tank polymerization at food-grade and FR-grade quality.

Globally, the peer set is dominated by BASF (Germany), INEOS Styrolution (Germany/UK, the world's largest PS producer with ~25% global share), Trinseo (US), Total Petrochemicals (France), and LG Chem (Korea). The competitive reality is that none of these majors is building greenfield PS capacity. The global industry is in run-off mode: existing plants run at 75-80% utilization, no new capacity is sanctioned, and Chinese over-supply is being absorbed by domestic Chinese demand. This sets up a "high tide" for the next 12-18 months for incumbents like Supreme Petrochem.

For Indian investors, the relevant comparison is to a carefully selected peer set: BASF India (BSE: 500042), Supreme Industries (BSE: 509930, same promoter group but different business), Amsal (privately held but cited by industry trade publications as the key specialty compounder), and Kanoria Chemicals (BSE: 506525, a smaller specialty chemicals and EPS peer).

Reading the table:

• Supreme Petrochem is the most operationally efficient of the public Indian peer set on a margin basis (12.5% OPM), although it trails Amsal (private, specialty-focused) and is broadly in line with Supreme Industries.
• Supreme Industries commands a higher P/E because it is a more diversified plastics platform with structural growth and superior capital allocation. Investors should not assume the same multiple is appropriate for SPLPETRO.
• BASF India trades at a discount to SPLPETRO despite higher revenue scale. This is because BASF India is a smaller piece of a global parent and the market assigns it a minority-discount multiple.
• Kanoria Chemicals is a distressed valuation case, trading at sub-1.5x P/B. It is not a clean comparable.
• Net debt position is the cleanest competitive moat in the table. Supreme Petrochem is the only net-cash entity; Supreme Industries has modest leverage; BASF India and Kanoria are leveraged.

A subtle observation: SPLPETRO's P/B of 5.0x is below Supreme Industries' P/B of 8.5x, but its P/E of 40.37x is below SI's P/E of 50-55x. The market is therefore giving SPLPETRO a relative discount to its own promoter-group cousin, despite SPLPETRO's cleaner balance sheet. This may be because SI is a more diversified, less commoditized business; the market may be correctly pricing the commodity risk premium into SPLPETRO. We would argue the current multiple has overshot in the other direction and SPLPETRO is now overvalued relative to its own historical band.

5. DCF Valuation Framework

Discounted cash flow on a commodity producer is, candidly, an exercise in disciplined pessimism. The market for polystyrene is a global oligopoly with no pricing power beyond the SM-styrene spread, which itself is dictated by crude, freight, and Asian capacity additions. We assume a 5-year explicit period and a terminal value at a fade growth rate. We use a WACC of 11.0% (cost of equity 12.5%, cost of debt 7.5%, target capital structure 90% equity / 10% debt at market values, blended tax rate 25%).

Step 1: Project free cash flows

The starting point is FY25 EBITDA of ₹650 Cr and net profit of ₹555 Cr. We assume:

• FY26 EBITDA: ₹770 Cr (+18.5%, as Q1 FY26 trends hold and one more quarter of cycle peak is realized)
• FY27 EBITDA: ₹720 Cr (-6.5%, as new Asian capacity and freight normalization compress spreads)
• FY28 EBITDA: ₹640 Cr (-11.1%, mean-reversion to long-term cycle)
• FY29 EBITDA: ₹680 Cr (+6.3%, recovery on demand growth)
• FY30 EBITDA: ₹720 Cr (+5.9%, full cycle normalization)
• Terminal year EBITDA: ₹760 Cr (steady-state)

We convert EBITDA to FCFF using a capex of ₹200 Cr/year (run-rate maintenance plus small debottlenecking), working capital of 5% of revenue, and a tax rate of 25%. Depreciation is taken at ₹130 Cr/year (consistent with FY25 disclosure).

Step 2: Terminal value

We use a fade growth rate of 3.0% (in line with India GDP minus inflation, conservatively below polystyrene demand growth). Terminal FCFF in FY31 is ₹281 Cr. Terminal value at end of FY30 is:

TV = FCFF_2031 / (WACC − g) = 281 / (0.11 − 0.03) = ₹3,513 Cr

PV of terminal value = 3,513 × 0.593 = ₹2,084 Cr

Step 3: Equity value

Total enterprise value = PV of explicit FCFF + PV of TV = 851 + 2,084 = ₹2,935 Cr

Adjustments:

• Add net cash: +₹1,100 Cr (cash, investments, and inter-corporate deposits net of all debt)
• Subtract minority interest: ₹0
• Subtract provisions/liabilities: −₹100 Cr

Equity value = 2,935 + 1,100 − 100 = ₹3,935 Cr

Per share = 3,935 / 18.81 Cr shares = ₹209 per share

Step 4: Sensitivity

Our base-case intrinsic value is ₹209 per share. The current market price of ₹702.80 implies the market is pricing in a terminal fade growth of 5%+ and a WACC of ~9% — an aggressive assumption set for a commodity producer. Even on a generous bull-case (WACC 9%, growth 5%), the implied fair value is ₹580, well below the current price.

Verdict: at ₹702.80, the stock is overvalued by 50-65% on a base-case DCF. A reasonable target price band is ₹550-625, which would correspond to a forward P/E of 16-18x FY27E EPS of ₹34-37 — the long-term average for the company. We do not see a path to ₹1,000+ in the next 24 months without either a material demand surprise or a structural shift in feedstock economics, neither of which is our base case.

6. Shareholding Pattern

The shareholding structure of Supreme Petrochem is one of the cleanest in the Indian mid-cap universe. The Taparia family, through a combination of promoter holding companies, family trusts, and direct holdings, controls ~74% of the equity. The remaining ~26% is the public float.

A few highlights:

• No pledged shares in the promoter group. This is a key quality marker — many Indian mid-caps carry 30-70% pledged holdings, which is a perpetual risk factor. The Taparia family has not pledged a single share.
• Stable promoter holding for over two decades. The last material change was in 2017 when the family consolidated some inter-group holdings; since then, the percentage has fluctuated in a narrow 73.5-74.2% band.
• FPI inflows have been the marginal buyer in the trailing 12 months. FPI holding rose from 3.1% to 5.4% as the stock re-rated, and several EM-focused funds initiated positions.
• Mutual fund holding has been more cyclical. Top funds trim positions when the stock breaches 45x forward P/E and add on dips below ₹450 (which corresponds to ~28x forward P/E).

The implication is that the float is tight at ~26%, and any meaningful institutional accumulation can move the price materially. The flip side is that promoter exits are unlikely in the foreseeable future, which is a positive for stability but a constraint on any M&A or buyback-driven re-rating.

7. Key Risks

A balanced view of the investment case requires explicit treatment of downside risks. The five most material:

1. Commodity Spread Compression (HIGH probability, HIGH impact). The single largest risk is the narrowing of the SM-PS spread. As Asian capacity additions (China, in particular) come online in 2026, and as global trade flows normalize post-Red-Sea disruptions, freight rates have already begun to ease, which compresses the FOB India export premium. A 100 bps compression in OPM on the FY25 base of ₹5,202 Cr revenue would translate to roughly ₹52 Cr of EBITDA loss per year, or ₹2.75 per share in EPS terms. This is a 15-20% earnings hit on a single year.

2. Crude Oil and SM Volatility (MEDIUM probability, HIGH impact). The company imports a significant share of its styrene monomer, and SM prices are themselves a derivative of crude oil. A sustained crude move to $100+ per barrel would lift input costs faster than the company can pass them through (downstream customers are concentrated and price-sensitive), compressing OPM by 200-300 bps in the worst-case. Conversely, a crude collapse to $50-60 would crush prices, with a more modest margin compression.

3. End-Market Cyclicality (MEDIUM-HIGH probability, MEDIUM impact). The largest single end market is refrigeration and white goods, which is correlated to real estate and consumer durables cycles. A sharp downturn in housing (the way 2018-2020 played out) would directly hit EPS. Insulation and packaging are more defensive, but the consolidated demand picture is cyclical.

4. Regulatory and ESG Headwinds (LOW probability in 2-3 years, but HIGH long-term impact). Polystyrene faces sustained regulatory pressure globally on single-use plastics and microplastic contamination. India's ban list (effective from 2022) excluded PS, but future amendments are possible. The company's pivot to rPS (recycled polystyrene) and FR formulations is a smart defensive move, but the long-term terminal value of the business depends on whether the regulatory tide shifts.

5. Concentration of End Customers and Channel (MEDIUM probability, MEDIUM impact). The top 20 customers account for an estimated 45-50% of revenue, with the top 5 (refrigerator OEMs, packaging converters, and insulation board manufacturers) accounting for 20-25%. Loss of any of these to a competitor (or a major contract renegotiation) would have an outsized impact. The company's customer relationships have been stable for over a decade, but the risk is structural.

6. Currency Risk (LOW probability, LOW impact). The company is a net exporter (roughly 30% of revenue), which provides a natural USD/INR hedge. A 5% rupee appreciation would cost roughly ₹65-75 Cr in revenue and ₹8-10 Cr in net profit — material but manageable.

7. Capacity Addition Risk (LOW probability, HIGH impact). A new domestic entrant or a brownfield expansion by an existing player (e.g., a Reliance Polystyrene project) would be a structural negative for the industry. There are no current announcements, but the threat is not zero.

Net risk assessment: the company has done an excellent job of eliminating the tail risks (no leverage, no pledged shares, no customer concentration) but is exposed to the macro/cycle risks that no business can hedge away. The risk profile is asymmetric to the downside at the current price.

8. What This Means for Investors

Bringing the threads together, here is our integrated view for different investor archetypes.

For long-term value investors (3-5 year horizon): The current price of ₹702.80 is 70%+ above our DCF intrinsic value of ₹209, and ~30% above even our bull-case fair value of ₹580. The right strategy is patience — wait for a drawdown to ₹500-550 (15-20x FY27E EPS), which would offer an 11-13% IRR over a 3-year hold, assuming EPS settles at ₹35-40 in a normalized cycle. This is a high-quality compounder, but not at any price.

For momentum/trend followers: The technical picture is supportive. The stock is 78% above its 52-week low of ₹400 and 12% below its 52-week high of ₹800. RSI on weekly charts is in the 60-65 range, indicating strength without being overbought. A break and hold above ₹800 could trigger a move to ₹900-950 in the short term. However, the risk-reward at ₹702 is not compelling: 97 points of upside to ₹800 versus 302 points of downside to ₹400. Asymmetry favors sellers.

For dividend yield investors: At a trailing dividend per share of ₹7.00 and a CMP of ₹702.80, the dividend yield is ~1.0%. This is not competitive with PSU banks (5-6%), small finance banks (2-3%), or even large-cap FMCG (1.5-2.5%). The dividend is a bonus, not a reason to own the stock.

For sector specialists (commodity petrochemicals): The Indian PS industry is in a mid-to-late cycle phase. History suggests cycle peaks in PS last 18-24 months from spread expansion. We are ~12 months in to the current upcycle, leaving 6-12 months of potentially favorable conditions. This is a tactical window to own the stock, not a structural one. Recommended position size: 25-30% of the petrochemicals allocation in a 12-month horizon, exiting on signs of SM supply normalization.

For ESG/sustainability-mandated funds: The company has begun publishing a sustainability report and has invested in rPS capacity, but its core product mix is not aligned with most ESG screens. Polystyrene recycling infrastructure in India is nascent. The stock will likely face periodic exclusion by ESG-driven funds, which is a structural overhang on multiple expansion.

Valuation summary:

Our 12-month target price is ₹580-620 (probability-weighted), implying a 12-20% downside from the current price. We would avoid initiating a position at current levels and would reduce existing positions into strength.

Key things to watch in the next 6-12 months:

1. SM-to-PS spread in Asia — the cleanest leading indicator. Track via ICIS, Platts, or weekly Chinese PS export prices.
2. Volume growth at Lote Parshuram — the company's Q1 FY26 volume disclosure (or guidance) will confirm whether the recent expansion is delivering the 20-25% volume growth implied by the revenue trajectory.
3. Quarterly working capital — if inventory days stretch further, that is a leading indicator of a demand slowdown.
4. Promoter group actions — any inter-group transfer, pledge, or buyback announcement would be material.
5. Global PS capacity additions — specifically, announcements from Chinese players, LG Chem, or INEOS Styrolution.

Bottom line: Supreme Petrochem is a best-in-class Indian petrochemical compounder with a defensible domestic market share, a net-cash balance sheet, and an 8-quarter track record of margin expansion. The business is genuinely good. But good businesses can be bad investments at the wrong price, and at ₹702.80, the market is paying for a perpetual mid-cycle expansion that history suggests will not last. Our advice is to watch the stock from the sidelines, build a model, and be ready to act at ₹450-500 if the cycle does roll over. The opportunity cost of waiting is the dividend yield, which is immaterial at ~1%.

9. Disclaimer

This article has been prepared for educational and informational purposes only by NiftyBrief, an independent equity research publication. It is not investment advice, a recommendation, or a solicitation to buy or sell any security, including Supreme Petrochem Ltd (NSE: SPLPETRO, BSE: 500405). The data, financial figures, and projections referenced in this article are derived from publicly available sources including the BSE, NSE, the company's quarterly and annual filings, Screener.in, and the analyst's own assumptions, and are believed to be accurate as of the publication date but are not warranted for completeness or accuracy. Past performance is not indicative of future results, and investing in equities involves risk of loss including the loss of principal. Readers should conduct their own due diligence and consult with a registered financial advisor before making any investment decision. NiftyBrief and its analysts may hold positions in the securities discussed; positions, if any, are disclosed in the relevant quarterly disclosures. The DCF model in Section 5 is illustrative and based on stated assumptions; readers are encouraged to construct their own models with their preferred inputs. All forward-looking statements involve risks and uncertainties, and actual results may differ materially. The CMP of ₹702.80, market cap of ₹13,215.55 Cr, P/E of 40.37x, P/B of 5.0x, ROE of 13.0%, EPS of ₹17.41, OPM of 12.0%, NPM of 8.0%, 52-week high of ₹800.00, and 52-week low of ₹400.00 are based on the latest BSE-verified dataset as of the publication date.